decitabine

A drug that is used to treat myelodysplastic syndromes and is being studied in the treatment of other types of cancer. It is a type of antimetabolite. Also called Dacogen.

English dictionary of cancer terms . 2015.

Look at other dictionaries:

  • Decitabine — Systematic (IUPAC) name 4 amino 1 (2 deoxy b D erythro pentofuranosyl) 1,3,5 triazin 2(1H) one Clinical data AHFS/ …   Wikipedia

  • decitabine — noun 5 aza 2 deoxycytidine, a cytosine analogue that hypomethylates DNA by inhibiting DNA methyltransferase …   Wiktionary

  • decitabine — de·ci·ta·bine (DAC) (de siґtə bēn″) an S phase specific cytotoxic compound used as an antineoplastic in the treatment of acute leukemia; administered by intravenous infusion …   Medical dictionary

  • Myelodysplastic syndrome — Classification and external resources ICD 10 D46 ICD 9 238.7 …   Wikipedia

  • Myelodysplasie — Klassifikation nach ICD 10 D46 Myelodysplastische Syndrome …   Deutsch Wikipedia

  • Myelodysplastische Syndrome — Klassifikation nach ICD 10 D46 Myelodysplastische Syndrome …   Deutsch Wikipedia

  • Myelodysplastisches Syndrom — Klassifikation nach ICD 10 D46 Myelodysplastische Syndrome …   Deutsch Wikipedia

  • DNA methylation — Illustration of a DNA molecule that is methylated at the two center cytosines. DNA methylation plays an important role for epigenetic gene regulation in development and disease. DNA methylation is a biochemical process that is important for… …   Wikipedia

  • Demethylating agent — Demethylating agents are compounds that can inhibit methylation, resulting in the expression of the previously hypermethylated silenced genes (see methylation: methylation and cancer for more detail). Cytidine analogs such as 5 azacytidine… …   Wikipedia

  • Azacitidine — Systematic (IUPAC) name 4 amino 1 β D ribofuranosyl 1,3,5 triazin 2(1H) one Clinical data Trade names …   Wikipedia

Share the article and excerpts

Direct link
Do a right-click on the link above
and select “Copy Link”

We are using cookies for the best presentation of our site. Continuing to use this site, you agree with this.